US Drug Recall Register
Class II · Moderate risk Terminated Initiated Jan 30, 2017 (10 years ago)

Glipizide extended-release tablets, 2.5mg, 30-count bottle, Rx Only, Manufactured By…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Dissolution Specifications. Above out of specification for dissolution rate observed at the 10 hour testing point.

What was recalled

Glipizide extended-release tablets, 2.5mg, 30-count bottle, Rx Only, Manufactured By Patheon Pharmaceuticals Inc Cincinnati OH 45237 USA, NDC 0591-0900-30, UPC 3-0591090030-4

Recalling firm
Actavis Inc
NDC code
0591-0900-30
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0476-2017

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Glipizide recalls

See all